Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 7.175
- -0.555-7.18%
Close May 6 16:00 ET
- 7.170
- -0.005-0.07%
Post 19:55 ET
1.14BMarket Cap-6.46P/E (TTM)
7.840High7.120Low1.90MVolume7.650Open7.730Pre Close13.85MTurnover1.53%Turnover RatioLossP/E (Static)159.30MShares11.77552wk High4.30P/B891.48MFloat Cap4.79052wk Low--Dividend TTM124.25MShs Float44.190Historical High--Div YieldTTM9.31%Amplitude1.995Historical Low7.274Avg Price1Lot Size
Ocular Therapeutix Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -27.59%349.68M | 100.25%392.1M | 100.25%392.1M | 286.45%427.22M | 590.16%459.69M | 511.05%482.89M | 91.40%195.81M | 91.40%195.81M | -8.60%110.55M | -50.49%66.61M |
| -Cash and cash equivalents | -27.59%349.68M | 100.25%392.1M | 100.25%392.1M | 286.45%427.22M | 590.16%459.69M | 511.05%482.89M | 91.40%195.81M | 91.40%195.81M | -8.60%110.55M | -50.49%66.61M |
| Receivables | -4.99%25.22M | 23.72%32.39M | 23.72%32.39M | 28.17%30.24M | 10.70%30.23M | 25.67%26.55M | 22.76%26.18M | 22.76%26.18M | 19.12%23.59M | 33.33%27.31M |
| -Accounts receivable | -4.99%25.22M | 23.72%32.39M | 23.72%32.39M | 28.17%30.24M | 10.70%30.23M | 25.67%26.55M | 22.76%26.18M | 22.76%26.18M | 19.12%23.59M | 33.33%27.31M |
| Inventory | 27.00%3.27M | 31.89%3.04M | 31.89%3.04M | 6.56%2.41M | 15.56%2.55M | 13.59%2.57M | 16.77%2.31M | 16.77%2.31M | 46.08%2.26M | 46.93%2.2M |
| Restricted cash | ---- | --0 | --0 | --0 | --0 | --150K | --150K | --150K | ---- | ---- |
| Other current assets | 24.22%9.52M | 72.66%13.46M | 72.66%13.46M | 170.49%13.15M | 33.16%6.12M | 61.53%7.67M | 93.50%7.79M | 93.50%7.79M | 46.53%4.86M | 20.84%4.59M |
| Total current assets | -25.42%387.69M | 89.89%440.99M | 89.89%440.99M | 234.86%473.01M | 395.06%498.59M | 385.08%519.82M | 79.16%232.24M | 79.16%232.24M | -2.99%141.26M | -37.18%100.71M |
| Non current assets | ||||||||||
| Net PPE | -5.12%16.61M | -15.80%15.33M | -15.80%15.33M | -18.69%15.74M | -15.88%16.89M | -10.88%17.51M | 1.75%18.21M | 1.75%18.21M | 72.88%19.36M | 82.81%20.08M |
| -Gross PPE | -5.12%16.61M | 1.29%38.97M | 1.29%38.97M | -18.69%15.74M | -15.88%16.89M | -10.88%17.51M | 9.37%38.47M | 9.37%38.47M | 72.88%19.36M | 82.81%20.08M |
| -Accumulated depreciation | ---- | -16.64%-23.63M | -16.64%-23.63M | ---- | ---- | ---- | -17.26%-20.26M | -17.26%-20.26M | ---- | ---- |
| Other non current assets | 0.00%1.61M | 0.00%1.61M | 0.00%1.61M | -8.50%1.61M | -8.50%1.61M | -8.50%1.61M | -8.50%1.61M | -8.50%1.61M | 0.00%1.76M | 0.00%1.76M |
| Total non current assets | -4.69%18.23M | -14.51%16.95M | -14.51%16.95M | -17.84%17.36M | -15.29%18.51M | -10.69%19.12M | 0.83%19.83M | 0.83%19.83M | 62.96%21.13M | 71.35%21.85M |
| Total assets | -24.68%405.92M | 81.68%457.94M | 81.68%457.94M | 201.98%490.37M | 321.92%517.09M | 319.18%538.95M | 68.84%252.06M | 68.84%252.06M | 2.40%162.38M | -29.19%122.56M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -28.31%4.63M | -4.85%4.18M | -4.85%4.18M | 0.43%4M | 3.28%3.69M | 18.60%6.45M | -14.33%4.39M | -14.33%4.39M | -24.94%3.98M | -3.54%3.57M |
| -accounts payable | -28.31%4.63M | -4.85%4.18M | -4.85%4.18M | 0.43%4M | 3.28%3.69M | 18.60%6.45M | -14.33%4.39M | -14.33%4.39M | -24.94%3.98M | -3.54%3.57M |
| Current accrued expenses | 93.77%31.08M | 22.50%35.12M | 22.50%35.12M | 5.41%30.45M | -0.98%24.36M | -27.07%16.04M | 18.96%28.67M | 18.96%28.67M | 33.65%28.89M | 26.47%24.6M |
| Current debt and capital lease obligation | 39.82%2.16M | 21.88%1.93M | 21.88%1.93M | -8.57%1.72M | -56.38%1.66M | -15.18%1.54M | -0.81%1.59M | -0.81%1.59M | 7.68%1.88M | 114.34%3.8M |
| -Current debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.08M |
| -Current capital lease obligation | 39.82%2.16M | 21.88%1.93M | 21.88%1.93M | -8.57%1.72M | -3.33%1.66M | -15.18%1.54M | -0.81%1.59M | -0.81%1.59M | 7.68%1.88M | -3.27%1.71M |
| Current deferred liabilities | -75.67%64K | -49.80%128K | -49.80%128K | -40.06%190K | -31.20%269K | -43.20%263K | -55.73%255K | -55.73%255K | -47.43%317K | -67.12%391K |
| Current liabilities | 56.09%37.93M | 18.51%41.35M | 18.51%41.35M | 3.69%36.36M | -7.37%29.97M | -18.23%24.3M | 11.15%34.9M | 11.15%34.9M | 19.81%35.07M | 23.91%32.36M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 1.65%74.07M | -9.72%73.85M | -9.72%73.85M | -9.53%73.41M | 20.11%73.23M | 16.04%72.86M | 30.50%81.8M | 30.50%81.8M | 40.01%81.14M | 5.68%60.97M |
| -Long term debt | 4.13%69.2M | -8.57%68.51M | -8.57%68.51M | -8.22%67.82M | 25.99%67.13M | 21.54%66.46M | 38.73%74.93M | 38.73%74.93M | 38.51%73.89M | 1.12%53.28M |
| -Long term capital lease obligation | -24.05%4.87M | -22.29%5.35M | -22.29%5.35M | -22.88%5.59M | -20.67%6.1M | -21.04%6.41M | -20.74%6.88M | -20.74%6.88M | 57.29%7.25M | 53.81%7.69M |
| Non current deferred liabilities | -0.48%14M | -0.96%14M | -0.96%14M | -1.39%14M | -1.78%14M | 5.46%14.07M | 5.59%14.14M | 5.59%14.14M | 4.91%14.2M | 9.65%14.25M |
| Derivative product liabilities | -29.41%13.85M | -55.83%13.25M | -55.83%13.25M | -39.78%14.47M | 87.37%22.08M | 51.96%19.62M | 372.16%29.99M | 372.16%29.99M | 107.19%24.02M | 12.64%11.78M |
| Other non current liabilities | 29.73%144K | 30.56%141K | 30.56%141K | 10.38%117K | 9.62%114K | 11.00%111K | 16.13%108K | 16.13%108K | --106K | --104K |
| Total non current liabilities | -4.31%102.06M | -19.67%101.24M | -19.67%101.24M | -14.63%101.99M | 25.61%109.42M | 19.65%106.67M | 52.74%126.03M | 52.74%126.03M | 43.79%119.47M | 7.34%87.11M |
| Total liabilities | 6.89%139.99M | -11.40%142.59M | -11.40%142.59M | -10.47%138.35M | 16.68%139.4M | 10.18%130.96M | 41.28%160.93M | 41.28%160.93M | 37.54%154.53M | 11.38%119.47M |
| Shareholders'equity | ||||||||||
| Share capital | 6.67%16K | 33.33%16K | 33.33%16K | 100.00%16K | 100.00%16K | 87.50%15K | 50.00%12K | 50.00%12K | 0.00%8K | 0.00%8K |
| -common stock | 6.67%16K | 33.33%16K | 33.33%16K | 100.00%16K | 100.00%16K | 87.50%15K | 50.00%12K | 50.00%12K | 0.00%8K | 0.00%8K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -25.28%-955.14M | -27.74%-891.08M | -27.74%-891.08M | -26.08%-842.7M | -20.72%-806.2M | -17.81%-762.43M | -13.09%-697.58M | -13.09%-697.58M | -11.15%-668.36M | -15.72%-667.84M |
| Paid-in capital | 4.33%1.22B | 52.96%1.21B | 52.96%1.21B | 76.68%1.19B | 76.46%1.18B | 78.18%1.17B | 20.93%788.7M | 20.93%788.7M | 4.43%676.2M | 4.36%670.92M |
| Total stockholders'equity | -34.82%265.93M | 246.03%315.34M | 246.03%315.34M | 4,382.63%352.02M | 12,135.02%377.7M | 4,101.25%407.98M | 157.59%91.13M | 157.59%91.13M | -83.01%7.85M | -95.31%3.09M |
| Total equity | -34.82%265.93M | 246.03%315.34M | 246.03%315.34M | 4,382.63%352.02M | 12,135.02%377.7M | 4,101.25%407.98M | 157.59%91.13M | 157.59%91.13M | -83.01%7.85M | -95.31%3.09M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now